Cytosorbents (CTSO) EBITDA Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -184.00 |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 1,505.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -763.00 |
| 10 | Cytosorbents | 22.59 Mn | 17.79 Mn | 6.13 Mn | 4,917.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,917.00 |
| Dec 31, 2025 | 2,020.00 |
| Sep 30, 2025 | 8,100.00 |
| Jun 30, 2025 | 6,078.00 |
| Mar 31, 2025 | 4,509.00 |
| Dec 31, 2024 | 5,158.00 |
| Sep 30, 2024 | -69.00 |
| Jun 30, 2024 | 58.00 |
| Mar 31, 2024 | -2,489.00 |
| Dec 31, 2023 | -8,650.00 |
| Sep 30, 2023 | -6,484.00 |
| Jun 30, 2023 | -3,596.00 |
| Mar 31, 2023 | -5,505.00 |
| Dec 31, 2022 | 541.00 |
| Sep 30, 2022 | -1,884.00 |
| Jun 30, 2022 | -4,013.00 |
| Mar 31, 2022 | -710.00 |
| Dec 31, 2021 | 317.00 |
| Sep 30, 2021 | -819.00 |
| Jun 30, 2021 | 3,181.00 |